Correlation between body mass index and prostate volume in benign prostatic hyperplasia patients undergoing holmium enucleation of the prostate surgery

[1] Foster HE(2019)Surgical management of lower urinary tract symptoms attributed to benign prostatic hyperplasia: AUA Guideline Amendment 2019 J Urol 202 592-598

[2] Dahm P(2016)Benign prostatic hyperplasia Nat Rev Dis Primers 2 16031-297

[3] Kohler TS(2016)Inflammatory mediators in the development and progression of benign prostatic hyperplasia Nat Rev Urol 13 613-495

[4] Lerner LB(2016)The epidemiology of benign prostatic hyperplasia associated with lower urinary tract symptoms: prevalence and incident rates Urol Clin N Am 43 259-1400

[5] Parsons JK(2000)Race, ethnicity and benign prostatic hyperplasia in the Health Professinals Follow-up Study J Urol 163 490-189

[6] Wilt TJ(2007)Race/ethnicity, obesity, health related behaviors and the risk of symptomatic benign prostatic hyperplasia: results from the prostate cancer prevention trial J Urol 177 1395-87

[7] McVary KT(2012)Urologic diseases in America P: evaluating racial/ethnic disparities in lower urinary tract symptoms in men J Urol 187 185-405

[8] Chughtai B(2014)Obesity is associated with larger prostate volume but not with worse urinary symptoms: analysis of a large multiethnic cohort Urology 83 81-272

[9] Forde JC(2006)The association between body size, prostate volume and prostate-specific antigen Prostate Cancer Prostatic Dis 10 137-355

[10] Thomas DD(2011)Effect of obesity on prostate-specific antigen, prostate volume, and international prostate symptom score in patients with benign prostatic hyperplasia Korean J Urol 52 401-11294

[1] Foster HE(2019)Surgical management of lower urinary tract symptoms attributed to benign prostatic hyperplasia: AUA Guideline Amendment 2019 J Urol 202 592-598

[2] Dahm P(2016)Benign prostatic hyperplasia Nat Rev Dis Primers 2 16031-297

[3] Kohler TS(2016)Inflammatory mediators in the development and progression of benign prostatic hyperplasia Nat Rev Urol 13 613-495

[4] Lerner LB(2016)The epidemiology of benign prostatic hyperplasia associated with lower urinary tract symptoms: prevalence and incident rates Urol Clin N Am 43 259-1400

[5] Parsons JK(2000)Race, ethnicity and benign prostatic hyperplasia in the Health Professinals Follow-up Study J Urol 163 490-189

[6] Wilt TJ(2007)Race/ethnicity, obesity, health related behaviors and the risk of symptomatic benign prostatic hyperplasia: results from the prostate cancer prevention trial J Urol 177 1395-87

[7] McVary KT(2012)Urologic diseases in America P: evaluating racial/ethnic disparities in lower urinary tract symptoms in men J Urol 187 185-405

[8] Chughtai B(2014)Obesity is associated with larger prostate volume but not with worse urinary symptoms: analysis of a large multiethnic cohort Urology 83 81-272

[9] Forde JC(2006)The association between body size, prostate volume and prostate-specific antigen Prostate Cancer Prostatic Dis 10 137-355

[10] Thomas DD(2011)Effect of obesity on prostate-specific antigen, prostate volume, and international prostate symptom score in patients with benign prostatic hyperplasia Korean J Urol 52 401-11294